Insulet (PODD) Stock Price
$298.3 2.3%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
9 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Insulet, AI stock picks, stock alerts and much more.
PODD AI Stock Analysis
AI stock analysis for PODD is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Insulet (PODD) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Insulet (PODD) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Insulet (PODD), currently trading at $298.3, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PODD
-
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
-
Symbol
PODD
-
Market
NASDAQ
-
Industry
Medical - Devices
-
Market Cap
21B
Similar Stocks
 |
Align Technology ALGN |
$203.6 1.1% |
5 |
 |
iRhythm Technologies IRTC |
$140.1 2.4% |
6 |
 |
Dexcom DXCM |
$89.06 0.3% |
5 |
 |
Bruker BRKR |
$40.9 2.8% |
5 |
 |
Treace Medical Concepts TMCI |
$5.54 1.1% |
4 |
News
PODD Alternative Data
Web Traffic
Insulet receives an estimated 120029 monthly visitors to insulet.com.
-
Web Traffic
120029
-
Change from Previous Month
3.8%
-
3 Month Change
4.8%
-
YoY Change
4.8%
Twitter Followers
Insulet has 8,045 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.2% over the last month.
-
Twitter Followers
8045
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Facebook Engagement
Insulet has engaged 27,846 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
27846
-
Daily Change
0.1%
-
1 Month Change
660.8%
-
3 Month Change
951.6%
-
YoY Change
951.6%
Instagram Followers
Insulet has 60,973 Instagram Followers on its main Instagram account, up by 1.8% over the last month.
-
Instagram Followers
60973
-
Daily Change
0%
-
1 Month Change
1.8%
-
3 Month Change
4.7%
-
YoY Change
4.7%
LinkedIn Followers
111,588 are following Insulet on LinkedIn, up by 2.2% over the last month.
-
LinkedIn Followers
111588
-
Daily Change
0.1%
-
1 Month Change
2.2%
-
3 Month Change
8%
Job Postings
Insulet currenly has an estimated 412 open job postings, up by 49.3% over the last month.
-
Job Postings
412
-
Daily Change
0.7%
-
1 Month Change
49.3%
-
3 Month Change
71.7%
-
YoY Change
71.7%
LinkedIn Employees
According to LinkedIn, Insulet has 4,206 employees, up by 1.8% over the last month.
-
LinkedIn Employees
4206
-
Daily Change
0.3%
-
1 Month Change
1.8%
-
3 Month Change
5.5%
-
YoY Change
5.5%
Reddit Mentions
Insulet has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Insulet is 80 out of 100 (bullish), down by -1.2% over the last month.
-
Business Outlook
80
-
Change from Previous Month
1.2%
-
3 Month Change
11.1%
-
YoY Change
11.1%
News Mentions
Insulet was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
PODD Financials
PODD Key Metrics
-
Total Revenue
$597.5M
-
Net Income
$100.7M
-
Earnings per Share
$1.54
-
Free cash flow
$91.7M
-
EBITDA
$141.5M
-
EBITDA Ratio
0.23682
-
Total Assets
$3.1B
PODD 2-year Revenue & Income
PODD 2-year Free Cash Flow
PODD Technicals
PODD SMA
PODD RSI
FAQ
What's the current price of Insulet (PODD) Stock?
The price of an Insulet (PODD) share is $298.3.
What's the market cap of Insulet?
The current market cap of Insulet is 21B.
Should I buy or sell PODD?
Multiple alternative data signals suggest that Insulet stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Insulet a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Insulet stock. The bullish indicators suggest that Insulet's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Insulet (PODD) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Insulet stock, given the bullish outlook.
What are some stocks similar to Insulet (PODD) that investors often compare it to?
Insulet (PODD) is often compared to similar stocks such as Align Technology, iRhythm Technologies, Dexcom, Bruker and Treace Medical Concepts.
What is the forecast for Insulet's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Insulet's stock price to be around $323 in 2026. Starting from the current price of $298.3, this represents a 8.3% change in price, indicating a bullish outlook for the stock.
How to buy Insulet (PODD) Stock?
Insulet stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Insulet shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.